Search results for Nucleolin antibody

Anti-Nucleolin antibody, Abcam, AB50279

Anti-Nucleolin antibody, Abcam, AB70493

Nucleolin antibody [NCL/902], Genetex, GTX34914

Nucleolin antibody [364-5], Genetex, GTX34916

Nucleolin antibody, C-term, Genetex, GTX47363

Nucleolin antibody, N-term, Genetex, GTX47364

Anti-Nucleolin antibody [130CT38.1.5], Abcam, AB86727

Want a custom formulation? This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact [email protected]

Anti-Nucleolin antibody [EPR7951], Abcam, AB134164

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Nucleolin antibody [EPR7952], Abcam, AB129200

What is this antibody validated in? Anti-Nucleolin antibody [EPR7952] (ab129200) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples. What is the molecular weight of Nucleolin? Anti-Nucleolin [EPR7952] (ab129200) specifically detects a band for Nucleolin (UniProt: P19338) at a molecular weight of 76kDa. Trusted by the scientific community Anti-Nucleolin [EPR7952] (ab129200) was first used in a scientific publication in 2012 and has been cited over 10 times in peer-reviewed journals. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Other related products We have a range of other formats of antibody clone [EPR7952] also available for your convenience: ab129200, Alexa Fluor® 488 - ab202708 , Alexa Fluor® 647 - ab202709 , Alexa Fluor® 555 - ab203417 , Carrier free - ab226113 , PE - ab305946 , APC - ab305947 , HRP - ab305948 , Alkaline Phosphatase - ab308818 , Alexa Fluor® 594 - ab310551 , Alexa Fluor® 568 - ab312558 , Alexa Fluor® 750 - ab321037 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-Nucleolin antibody [EPR7952], Abcam, AB305946

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .